GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Daehan New Pharm Co Ltd (XKRX:054670) » Definitions » Sale Of Investment

Daehan New Pharm Co (XKRX:054670) Sale Of Investment : ₩6,281 Mil (TTM As of Sep. 2024)


View and export this data going back to 2002. Start your Free Trial

What is Daehan New Pharm Co Sale Of Investment?

Daehan New Pharm Co's sale of investment for the three months ended in Sep. 2024 was ₩2,851 Mil. It means Daehan New Pharm Co gained ₩2,851 Mil from selling investments. Daehan New Pharm Co's sale of investment for the trailing twelve months (TTM) ended in Sep. 2024 was ₩6,281 Mil.

Compared with last quarter (₩3,104 Mil in Jun. 2024 ), Daehan New Pharm Co gained less money from selling investments in Sep. 2024 (₩2,851 Mil).

Daehan New Pharm Co Sale Of Investment Historical Data

The historical data trend for Daehan New Pharm Co's Sale Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Daehan New Pharm Co Sale Of Investment Chart

Daehan New Pharm Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Sale Of Investment
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3,066.99 8,020.00 2,657.80 4,994.26 1,731.05

Daehan New Pharm Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Sale Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 417.22 - 325.80 3,104.29 2,850.63

Daehan New Pharm Co Sale Of Investment Calculation

Sale of Investments represents cash inflow on the sale of investments in securities.

Sale Of Investment for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩6,281 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Daehan New Pharm Co Sale Of Investment Related Terms

Thank you for viewing the detailed overview of Daehan New Pharm Co's Sale Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.

Daehan New Pharm Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Daehan New Pharm Co Ltd (XKRX:054670) » Definitions » Sale Of Investment
Comparable Companies
XKRX:330350 XKRX:000230 XKRX:067290 XKRX:072020 XKRX:063160 XKRX:002720 XKRX:389470 XKRX:004310 XKRX:002800 XKRX:183490 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
N/A
Address
1062-4 Namhyeon-dong, Gwanak-gu, Seoul, KOR, 137-851
Website
http://www.dhnp.co.kr
Daehan New Pharm Co Ltd is a South Korea based company operating in the pharmaceutical sector. It is engaged in producing pharmaceutical products, animal health and nutrition, and bio products. The pharmaceutical products are tertan tab, amloc tab, tarocin SR tab, NP star tab and others. The animal health and nutrition products are starvac, pigcoc for calves, ocean doctor, and others. The bio range of the products by the group are CELRENA serum-free, BMPro serum-free, BMPro-V serum-free, ALyS505NK-EX serum-free and others.

Daehan New Pharm Co Headlines

No Headlines